79 下列何種單株抗體可用於癌症治療?
(A) Basiliximab
(B) Adalimumab
(C) Rituximab
(D) Daclizumab
答案:登入後查看
統計: A(93), B(104), C(999), D(95), E(0) #411430
統計: A(93), B(104), C(999), D(95), E(0) #411430
詳解 (共 7 筆)
#1006521
Rituximab為CD20之單株抗體:CD20抗原幾乎存在於所有B-淋巴球的表面。而超過百分之九十之低惡性度非何杰金氏淋巴瘤都是B-細胞所構成,它們都含有CD20抗原。且CD20抗原不存在於在較為早期之造血幹細胞(stem cell)、早期前B-細胞(early pre-B cell)、正常的漿細胞,因此這項治療並不會影響造血功能。
15
1
#3480374
(A) Basiliximab
(B) Adalimumab
(C) Rituximab
(D) Daclizumabn
黃底是作用部位 紅底是抗體來源
13
0
#3410660
(A) Basiliximab 腎移植抗排斥用,和CD25結合阻止IL-2生成
(B) Adalimumab 抗風濕藥物,阻斷TNF-a,為IgG1單株抗體
(C) Rituximab 可治療非何杰金氏淋巴瘤,和CD20結合
(D) Daclizumab 腎移植抗排斥用,和CD25結合阻止IL-2生成
10
0
#876634
Rituximab is a chimeric monoclonal antibody against the protein CD20, which is primarily found on the surface of immune system B cells. Rituximab destroys B cells and is therefore used to treat diseases which are characterized by excessive numbers of B cells, overactive B cells, or dysfunctional B cells. This includes many lymphomas, leukemias, transplant rejection, and autoimmune disorders. 可治療風濕性關節炎
5
0